We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
01 20Alfred E Tiefenbacher GmbH
02 5Pharmathen SA
03 7Actavis Inc
04 3Alkem Laboratories
05 1Biodeal Pharmaceuticals
06 6CHEMO
07 9Collegium Pharmaceutical
08 8ENDO OPERATIONS LTD.
09 5GL Pharma
10 38Grunenthal
11 12Grünenthal GmbH
12 11Grünenthal GmbH,
13 2Health Biotech
14 2Hubei Gedian Humanwell Pharmaceutical
15 5Johnson & Johnson Innovative Medicine
16 3Novagen Healthcare
17 10ORIFARM GROUP AS
18 9Orchid Pharma
19 7Precise Group
20 2RHODES PHARMACEUTICALS LP
21 3ROXANE
22 5Sandoz B2B
23 5Seqirus
24 12Spirig Healthcare
25 1Vega Biotech Pvt. Ltd.
26 4West-ward Pharmaceutical Corp
27 24Blank
01 1Antic-calc Tablet, Film Coated
02 20Depot tablet
03 10Depottablett
04 7ER TABLET
05 4ER Tablet
06 10Extended Release Tablets
07 12Extended-Release Tablet
08 4FILM COATED PILL
09 6Film Coated Tablet
10 1Film-Coated Tablets
11 5Filmtabl
12 1L?s
13 2Mixture, solution
14 1Nasal Spray
15 2ORAL SOLUTION
16 6PROLONGED-RELEASE TABLET
17 5Prolonged Release Tablet
18 24Ret Tabl
19 2SOLUTION;ORAL
20 12SR Tablet
21 3SRT
22 4Solution
23 2TAB
24 3TABLET
25 5TABLET (EXTENDED-RELEASE)
26 3TABLET (IMMEDIATE RELEASE)
27 14TABLET, EXTENDED RELEASE;ORAL
28 2TABLET; ORAL
29 12TABLET;ORAL
30 14Tablet
31 1Tablet, film-coated
32 1Tapentadolo 100Mg 30 Joined' Oral Use Rp
33 1Tapentadolo 150Mg 30 Joined' Oral Use Rp
34 1Tapentadolo 200Mg 30 Joined' Oral Use Rp
35 1Tapentadolo 250Mg 30 Joined' Oral Use Rp
36 1Tapentadolo 25Mg 40 Combined Oral Use Rp
37 1Tapentadolo 50Mg 30 Joined' Oral Use Rp
38 10XR Tablet
39 5Blank
01 1DISCN
02 2EU Dossier Readiness-Q1 2020
03 4EU Dossier Readiness-Q3 2019
04 8Generic
05 9Generic EU CTD
06 8Narcotic (CDSA I)
07 5Originator
08 8RX
09 14Status- Early Development
10 12Under registration in India
11 148Blank
01 160 Palexia Retard 100Mg Extended Release Tablets
02 160 Palexia Retard 150Mg Extended Release Tablets
03 160 Palexia Retard 200Mg Extended Release Tablets
04 160 Palexia Retard 250Mg Extended Release Tablets
05 160 Palexia Retard 25Mg Extended Release Tablets
06 160 Palexia Retard 50Mg Extended Release Tablets
07 160 Yantil Retard 100Mg Extended Release Tablets
08 160 Yantil Retard 150Mg Extended Release Tablets
09 160 Yantil Retard 200Mg Extended Release Tablets
10 160 Yantil Retard 250Mg Extended Release Tablets
11 160 Yantil Retard 25Mg Extended Release Tablets
12 160 Yantil Retard 50Mg Extended Release Tablets
13 4NUCYNTA
14 5NUCYNTA ER
15 5NUCYNTA EXTENDED-RELEASE
16 3NUCYNTA IR
17 35Palexia
18 1Palexia 100 mg
19 1Palexia 50 mg
20 16Palexia Depot
21 5Palexia SR
22 1Palexia SR 100 mg
23 1Palexia SR 200 mg
24 1Palexia SR 50 mg
25 20Palexia depot
26 5TADOMON
27 5TAPELOD
28 16TAPENTADOL
29 5TAPENTADOL HYDROCHLORIDE
30 1Tapencet ER
31 1Tapentadol Hydrochloride
32 12Tapentadol Spirig HC retard
33 64Blank
01 5Australia
02 8Canada
03 20Germany
04 5Greece
05 35India
06 16Italy
07 34Norway
08 5South Africa
09 18Spain
10 12Sweden
11 31Switzerland
12 30USA
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q3 2019
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : XR Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Early Development
Registration Country : Germany
Brand Name :
Dosage Form : Solution
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Early Development
Registration Country : Germany
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : NUCYNTA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2008-11-20
Application Number : 22304
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NUCYNTA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 75MG BASE
Packaging :
Approval Date : 2008-11-20
Application Number : 22304
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NUCYNTA
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-11-20
Application Number : 22304
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NUCYNTA ER
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2011-08-25
Application Number : 200533
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NUCYNTA ER
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2011-08-25
Application Number : 200533
Regulatory Info : RX
Registration Country : USA
